Phenanthroline

Phenanthroline

SCHEMBL21060516

N.N.c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.94
CCR8 P51685 5/20 0.94
LMNA P02545 4/20 0.94
CCR5 P51681 3/20 0.94
KDM4E B2RXH2 3/20 0.94
MMP2 P08253 2/20 0.94
TSHR P16473 2/20 0.94
MAPT P10636 2/20 0.94
HTT P42858 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
TDP1 Q9NUW8 2/20 0.94
GMNN O75496 1/20 0.94
TP53 P04637 1/20 0.94
HSP90AA1 P07900 1/20 0.94
CYP3A4 P08684 1/20 0.94
CYP2D6 P10635 1/20 0.94
MMP9 P14780 1/20 0.94
ALOX15 P16050 1/20 0.94
NFKB1 P19838 1/20 0.94
MMP8 P22894 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthroline SCHEMBL11832296 1.00 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29354015 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL29367277 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8845760 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL8312 0.97 CCR1 (1.00) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL22982126 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21044608 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL22462277 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL21300488 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E
Phenanthroline SCHEMBL6410050 0.94 CCR1 (0.94) CCR1CCR8LMNACCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655153-B2 Extended absorbance solar leaf and methods of making INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2023-05-23 US claimed
US-20200048094-A1 EXTENDED ABSORBANCE SOLAR LEAF AND METHODS OF MAKING INTERNATIONAL BUSINESS MACHINES CORPORATION 2020-02-13 US claimed
US-11655153-B2 Extended absorbance solar leaf and methods of making INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2023-05-23 US disclosed
US-20200048094-A1 EXTENDED ABSORBANCE SOLAR LEAF AND METHODS OF MAKING INTERNATIONAL BUSINESS MACHINES CORPORATION 2020-02-13 US disclosed
US-20190185326-A1 EXTENDED ABSORBANCE SOLAR LEAF AND METHODS OF MAKING INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048094-A1 EXTENDED ABSORBANCE SOLAR LEAF AND METHODS OF MAKING GNE, ADAR, SELE CCR1 4723/4885CCR8 3500/4885LMNA 2063/4885
US-20190185326-A1 EXTENDED ABSORBANCE SOLAR LEAF AND METHODS OF MAKING NCL, CRY1, NQO1 CCR1 4883/4885CCR8 4715/4885LMNA 653/4885
US-11655153-B2 Extended absorbance solar leaf and methods of making GNE, ADAR, SELE CCR1 4723/4885CCR8 3500/4885LMNA 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.